Introduction
Neural Signals Inc. is a C corporation based and incorporated in the State of Georgia USA in 1989. It was primarily a research company that it has transitioned into providing a speech prosthetic for those who are locked-in, that is paralyzed and mute, but alert and intelligent. It has been funded by the Small Business Innovative Research program of the National Institutes of Health. It has received over $4 million in funding to date in collaboration with other scientists listed under the Partners tab. Now, most importantly, it is working in collaboration with Dark Pulse Inc. (a public company) as a joint venture called Neural Logistics LLC.
DUNS number : 129130964
Our Strategy
We intend to take the company public in collaboration with Dark Pulse Inc. Our immediate aim is to test the newer version of the Neurotrophic Electrode in rats. On completion we will apply for permission to implant locked-in humans for restoration of speech. Following that, we fully intend to work on enhancing brains of healthy people.
Our History
The Neurotrophic Electrode is the essential technology on which the whole effort is based. It was first developed at the Georgia Institute of Technology, Atlanta, Georgia, and implanted in rats in 1986. Dr. Roy A. E. Bakay was instrumental in performing monkey implants of the electrode at Yerkes Primate Center, Emory University, Atlanta Georgia from 1989 to 1992. Following those successful studies, the first human implant was performed in 1996 with FDA permission at Emory University. Six human subjects have been implanted to date, the last (PK) being in 2014. The first four were aimed at providing communication to a computer in order to produce synthesized speech slowly spelled out letter by letter. Subject 5 was implanted with the aim of providing near-conversational speech of several short but useful words and phrases. Details of this successful implant are in the publications in the Research section. Subject 6 is Dr. Kennedy whose data showed that silent speech can be detect just as easily as audible speech. See the Research tab for publications on his and other’s results.